Learn how Prognos Health and Datavant are transforming & improving the way life sciences can access an extensive network of integrated real world data sources to define an ideal patient cohort as well as key demographic, therapeutic & customer insights. Understand how an enhanced ability to identify & select patient-level data speeds time to value over the traditional method of linking, purchasing & mining data from multiple sources over many months of time. Join Theresa Greco, Chief Commercial Officer, Prognos Health, & Su Huang, Head of Data Strategy, Datavant, & see it’s now possible to access and design a HIPAA-compliant, multi-source patient cohort that is application-ready in a matter of minutes. The benefits of purchasing fit-for-purpose data from the Prognos Marketplace include:

  • Unprecedented flexibility in selecting cohort criteria
  • Expansive ecosystem linkable via Datavant tokenization engine
  • One patient-centric Marketplace to acquire all relevant and complementary records 
  • One vendor and contract for acquisition of multi-source data
  • Delivery within hours of contract signature
  • Flexible BYOD options including secure private cloud

Featured Speakers

Theresa Greco

Chief Commercial Officer
Prognos Health

Theresa is a transformational executive leader with the unique ability to innovate, operate, sell and deliver. She has over 20 years’ experience in healthcare and information services fulfilling key executive roles in general management, business development, product strategy and development and consulting/professional services. Theresa is recognized by her peers for consistently delivering profitable revenue growth against objectives and accurately identifying market opportunities for R&D investment to fuel corporate growth. Theresa has held leadership roles at MMIS Health, LexisNexis Risk Solutions, Health Market Science and CSC. Theresa holds a B.S. degree from Ursinus College in Exercise Sports Science and an M.B.A. in Healthcare Administration and Management from Temple University.

Su Huang

Head of Data Strategy
Datavant

Su supports Datavant's partners in identifying and understanding the data ecosystem. Prior to Datavant, Su held a variety of roles at Invitae, a genetic testing company, from leading market access to growing the client services function. Beyond diagnostics, she has also supported commercialization and market access strategy for new biopharma and medical device products at IMS Consulting Group and Abbott Vascular. Su received degrees in Finance and Systems Engineering from the University of Pennsylvania, and holds an MBA and MS in Education from Stanford University.

Melissa Leonhauser

Vice President of Product Strategy
Prognos

Melissa Leonhauser is an experienced product manager and marketer in the healthcare industry. She is currently the Vice President of Product Strategy at Prognos, Life Sciences. Leonhauser has spent most of her career creating and managing analytic solutions that support pharmaceutical brand teams. She has helped introduce and shape how pharmaceutical manufacturers use Real World Data to understand the patient journey and inform their decision making. Prior to joining Prognos, Leonhauser managed solutions for IQVIA, SDI, and Verispan and supported cardiovascular and respiratory brands at Kos Pharmaceuticals.


NOW AVAILABLE ON DEMAND